title: The impact of new drugs on management of glaucoma in Scotland: observational study.
authors.affiliation: National Poisons Information Service, Edinburgh, United Kingdom.
authors.forename: D N
authors.initials: DN
authors.lastname: Bateman
authors.forename: R
authors.initials: R
authors.lastname: Clark
authors.forename: A
authors.initials: A
authors.lastname: Azuara-Blanco
authors.forename: M
authors.initials: M
authors.lastname: Bain
authors.forename: J
authors.initials: J
authors.lastname: Forrest
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000068438:Brimonidine Tartrate; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004363:Drug Utilization / Q000639:trends*; D005901:Glaucoma / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000639:trends*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D012606:Scotland; D014130:Trabeculectomy / Q000706:statistics & numerical data / Q000639:trends
chemical_list: D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D011465:Prostaglandins, Synthetic; D011810:Quinoxalines; D000068438:Brimonidine Tartrate